Speakers

Phil Morton

Chief Technology Officer • Albumedix

Dr. Philip Morton has a strong technology background with over 25 years’ experience in the biopharmaceutical industry within process and product development as well as product application research. He was trained as a biochemical engineer and has biopharmaceutical experience in both R&D and manufacturing environments in Albumedix under its former owners of Delta Biotechnology, Aventis and Novozymes. With his experience Phil brings a strong technological leadership to Albumedix.

Also Speaking

Lisa Deschamps

Chief Executive Officer • AviadoBio

Becky Johnson-Kent

Vice President, Europe & Women in Advanced Therapies (WiAT) Programme Lead • Phacilitate

Jennifer Fenwick

Senior Manager, Personalized Supply Chain • World Courier

Also Speaking

Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.
Image

Briefings

Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.